콘텐츠로 건너뛰기
Merck
  • Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia.

Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia.

Neurology (2015-01-23)
Alexander Lossos, Claudia Stümpfig, Giovanni Stevanin, Marion Gaussen, Bat-El Zimmerman, Emeline Mundwiller, Moriya Asulin, Liat Chamma, Ruth Sheffer, Adel Misk, Shlomo Dotan, John M Gomori, Penina Ponger, Alexis Brice, Israela Lerer, Vardiella Meiner, Roland Lill
초록

To present the clinical, molecular, and cell biological findings in a family with an autosomal recessive form of hereditary spastic paraplegia characterized by a combination of spastic paraplegia, optic atrophy, and peripheral neuropathy (SPOAN). We used a combination of whole-genome linkage analysis and exome sequencing to map the disease locus and to identify the responsible gene. To analyze the physiologic consequences of the disease, we used biochemical and cell biological methods. Ten members of a highly consanguineous family manifested a childhood-onset SPOAN-like phenotype with slow progression into late adulthood. We mapped this disorder to a locus on chromosome 1q and identified a homozygous donor splice-site mutation in the IBA57 gene, previously implicated in 2 infants with lethal perinatal encephalomyopathy. This gene encodes the mitochondrial iron-sulfur (Fe/S) protein assembly factor IBA57. In addition to a severely decreased amount of normal IBA57 messenger RNA, a patient's cells expressed an aberrantly spliced messenger RNA with a premature stop codon. Lymphoblasts contained 10-fold-lower levels of wild-type, but no signs of truncated IBA57 protein. The decrease in functional IBA57 resulted in reduced levels and activities of several mitochondrial [4Fe-4S] proteins, including complexes I and II, while mitochondrial [2Fe-2S] proteins remained normal. Our findings reinforce the suggested specific function of IBA57 in mitochondrial [4Fe-4S] protein maturation and provide additional evidence for its role in human disease. The less decreased IBA57 protein level in this family explains phenotypic differences compared with the previously described lethal encephalomyopathy with no functional IBA57.

MATERIALS
제품 번호
브랜드
제품 설명

USP
Alpha Lipoic Acid, United States Pharmacopeia (USP) Reference Standard
Thioctic acid containing impurity B, European Pharmacopoeia (EP) Reference Standard
Thioctic acid, European Pharmacopoeia (EP) Reference Standard
Thioctic acid for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
(±)-α-Lipoic acid, ≥98.0%
Sigma-Aldrich
(±)-α-Lipoic acid, suitable for cell culture, BioReagent, ≥99%
Sigma-Aldrich
(±)-α-Lipoic acid, synthetic, ≥99% (titration), powder
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)